TOKYO -- Keio University is joining hands with Cyberdyne to develop treatments for spinal cord injuries that combine induced pluripotent stem cell therapy with the startup's wearable cybersuit.
Biotechnology
TOKYO -- Keio University is joining hands with Cyberdyne to develop treatments for spinal cord injuries that combine induced pluripotent stem cell therapy with the startup's wearable cybersuit.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.